Fig. 1From: Development and clinical applications of cancer immunotherapy against PD-1 signaling pathwayComplete Spectrum of adverse events associated with cancer immunotherapy. Depicted are common immune-related adverse events in patients treated with immune checkpoint blockade (modified from Festino L. and Ascierto P.A. (2018) “Side Effects of Cancer Immunotherapy with Checkpoint Inhibitors.” In: Zitvogel L., Kroemer G. (eds) Oncoimmunology. Springer, Cham)Back to article page